Relief Therapeutics Holding AG (RLFTF)

[elllk]

Right now nothing will bring significantly more attention to Aviptadil (Zyesami; RLF-100) than getting the EUA. And we already know that even Fauci and other important people in the COVID effort know about Zyesami. Once the EUA comes through money will start coming in and then the powers that be with Zyesami can start developing a real long term marketing team. They don't have the resources to do that right now and, in any case, the most important force at play right now is the FDA which does not pay attention to marketing efforts. Their resources and efforts currently need to be directed at the FDA and the trial results.